What to Expect From CSX Earnings
CSX is scheduled to report its fourth-quarter financial results after the markets close on Tuesday.
All Work
Chris Lange
Ascena Retail Drops on Holiday Performance
Ascena Retail led the bears in Tuesday’s session as the result of a less-than-favorable holiday season.
Why Key Analyst Sees CarMax Bouncing Over 30% Off Its Lows
CarMax, like all the broad markets, is currently posting a loss for 2016. But this might prove to be a buying opportunity, Oppenheimer believes.
Why Merrill Lynch Upgraded Apple Now and Sees Many 2016 Catalysts
Apple might not be one of the best performing Dow stocks of 2016 thus far, but one key analyst believes that it could rise over 30% this year.
Are Alcoa’s Earnings the Start of a Turnaround?
Alcoa reported mixed fourth-quarter financial results and a update on its coming split after the markets closed on Monday.
Meet the SEC’s Examination Priorities for 2016
The U.S. Securities and Exchange Commission (SEC) has announced 2016 priorities of its Office of Compliance Inspections and Examinations (OCIE).
Halozyme Therapeutics Sinks on Business Update
Halozyme Therapeutics hit a new 52-week low in Monday's session following the release of a business update at JPMorgan’s 34th Annual Healthcare Conference.
Celgene Disappoints Investors by Meeting Estimates
Celgene Corp. (NASDAQ: CELG) sank in Monday's session after providing a business update that was largely in line with analyst expectations.
Anavex Soars on Positive Alzheimer’s Results
Anavex Life Sciences was one of the stocks helping to prop up the market in Monday’s session.
What to Expect From Alcoa Earnings
Alcoa is scheduled to release its fourth-quarter earnings after the markets close on Monday, kicking off a new earnings season.
Elevate Credit Releases Potential Pricing for IPO
Elevate Credit has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Acorn Proves Investors Still Willing to Buy Into Chinese Growth Story
Acorn International led the bulls in Monday’s session following the announcement of a newly authorized share repurchase plan.
Clearside Files for IPO
Clearside Biomedical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Apollo Education Rises Despite Missed Earnings
Apollo Education Group reported disappointing fiscal first-quarter financial results before the markets opened on Monday.
Is Thermo Fisher Overpaying for Affymetrix?
Affymetrix was absolutely soaring early on Monday on word that it will be acquired. Thermo Fisher Scientific is the buyer.
5 Top Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Alcoa and some of the major companies reporting their quarterly results this week.
5 Stocks That Destroyed Shareholders This Past Week
24/7 Wall St. has tracked five companies in which shareholders were hurt by bad news in the first week of trading for 2016.
SEC Bars Hedge Fund Manager From Supervisory Role
The U.S. Securities and Exchange Commission (SEC) announced that hedge fund manager Steven A. Cohen will be prohibited from supervising funds that manage outside money until 2018 in order to settle charges for failing…
Athersys Soars on Japanese License Deal
Athersys has announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy treatments.
Container Store Tanks on Missed Earnings and Guidance
Container Store reported disappointing fiscal third-quarter financial results after the markets closed on Thursday.